Advertisement
Imaging
Subscribe to Imaging
View Sample

FREE Email Newsletter

New researcher needs in the lab mean new challenges for architects

December 21, 2010 7:35 pm | by Mass High Tech: The Journal of New England Technology | News | Comments

In an effort to create more open laboratory spaces to provide easier access to other people and shared equipment, architects are taking a closer look at support space, areas such as cold rooms, tissue culturing rooms, and other specialized spaces where researchers spend a lot of time.

Takeda Completes Settlements With All Defendants in U.S. Patent Litigation Involving ACTOS® (pioglitazone HCI), ACTOplus met® (pioglitazone HCl and metformin HCl) and duetac...

December 21, 2010 5:35 pm | by Bio-Medicine.Org | News | Comments

DEERFIELD, Ill. and OSAKA, Japan, Dec. 21, 2010 /- Takeda Pharmaceutical Company Limited ("Takeda") today announced that Takeda and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc. ("TPNA"), have completed settlements with all defendants in patent litigation brought...

MiMedx Announces Agreement to Acquire Surgical Biologics

December 21, 2010 5:35 pm | by Bio-Medicine.Org | News | Comments

MARIETTA, Ga., Dec. 21, 2010 /- MiMedx Group, Inc. (OTC Bulletin Board: MDXG ), an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today that it has signed a definitive agreement to acquire Surgical Biologics, a leader in the...

Advertisement

Advanced Laser Therapy Solutions for Women's Hair Loss

December 20, 2010 10:31 pm | by Bio-Medicine.Org | News | Comments

LONDON, Dec. 21, 2010 /- Many Women suffering from hair loss are turning to Advanced Hair Studio s and discovering advanced laser therapy as a method along with other procedures to overcome thinning hair. This method of hair restoration has been shown to be affective in helping a woman's...

Silence Therapeutics Provides Year-end Update

December 20, 2010 10:31 pm | by Bio-Medicine.Org | News | Comments

LONDON, Dec. 21, 2010 /- Silence Therapeutics plc (AIM: SLN) ("Silence" or the "Company"), a leading global biotechnology company dedicated to the discovery, development and delivery of targeted, systemic RNA interference (RNAi) therapeutics for the treatment of serious diseases, today...

Boston Scientific Announces Election of Dr. Kristina M. Johnson to its Board of Directors

December 20, 2010 12:33 pm | by Boston Scientific | News | Comments

NATICK, Mass., Dec. 20, 2010 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced that the Company's Board of Directors has elected Kristina M. Johnson, Ph.D., as a Director, effective January 1

The Center for Business Intelligence (CBI) Receives Top 100 Women-Led Businesses Award

December 20, 2010 10:34 am | by Bio-Medicine.Org | News | Comments

WOBURN, Mass., Dec. 20, 2010 /- The Center for Business Intelligence (CBI) has been recognized as a Top 100 Women-Led Business in Massachusetts in 2009. The honor was awarded recently to Kathleen Y. Coffey, CBI President, by the Boston Business Journal and The Commonwealth Institute at...

FDA CONSUMER HEALTH INFORMATION - Generic Drug Roundup: December 2010

December 20, 2010 10:33 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., Dec. 20, 2010 /PRNewswire-USNewswire/ -- Each year, the Food and Drug Administration (FDA) approves many generic drugs that treat a wide variety of conditions and help consumers save money. To read about recent significant FDA approvals for generic medications, go to...

Advertisement

Varian Medical Systems Schedules First Quarter FY2011 News Release and Conference Call

December 20, 2010 5:34 am | by Bio-Medicine.Org | News | Comments

PALO ALTO, Calif., Dec. 20, 2010 /- Varian Medical Systems (NYSE: VAR ) announced today that it will report results for first quarter of fiscal year 2011 following the close of regular trading on Wednesday, January 26, 2011.  The news release will be followed by a teleconference...

St Helens & Knowsley Teaching Hospitals NHS Trust wins healthcare IT category at the 2010 Health Business Awards

December 20, 2010 3:37 am | by RealWire | News | Comments

The third award received this year for landmark electronic medical records project December 20, 2010 - C Cube Solutions and Kodak (NYSE:EK) today announce that Merseyside-based St Helens & Knowsley Teaching Hospitals NHS Trust has won the healthcare IT category at the 2010 Health...

Regeneron Schedules December 20, 2010 Teleconference and Webcast to Discuss Results of VEGF Trap-Eye Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and Phase 2 Study i...

December 19, 2010 11:32 pm | by Bio-Medicine.Org | News | Comments

TARRYTOWN, N.Y., Dec. 20, 2010 /- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) today announced that it will hold a teleconference and webcast at 8:30 a.m. Eastern Time on Monday, December 20, to discuss results of the Phase 3 COPERNICUS study with VEGF Trap-Eye in central retinal vein...

An ITG Majestic Market Research Study Indicates a Bright Future for Gilenya, Despite Concerns About Its Safety

December 17, 2010 7:31 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Dec. 17, 2010 /- A study published this week by ITG (NYSE: ITG ) revealed that Novartis recently approved drug, Gilenya, has already taken share from market leaders in the multiple sclerosis (MS) market, and uptake is expected to increase significantly over the next year.  ...

Drug Combinations That May Cause Major Drug Interactions Common Among Seniors Who Take Antidepressants, According to Thomson Reuters Research

December 17, 2010 2:31 am | by Bio-Medicine.Org | News | Comments

ANN ARBOR, Mich., Dec. 17, 2010 /- More than half of older Americans who were prescribed antidepressants for the first time were already taking a medication that could adversely interact with the antidepressant , according to a new study from Thomson Reuters. For one-fourth of the seniors...

Advertisement

Jennerex and Transgene Announce Initiation of Clinical Trial of Intravenous JX-594 in Patients With Refractory Metastatic Colorectal Cancer

December 15, 2010 11:32 pm | by Bio-Medicine.Org | News | Comments

SAN FRANCISCO and ILLKIRCH, France, Dec. 16, 2010 /- Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Transgene (NYSE Euronext Paris: FR0005175080), a...

Watson and Richter Announce Exclusive License Agreement for Esmyaâ„¢

December 15, 2010 11:32 pm | by Bio-Medicine.Org | News | Comments

MORRISTOWN, N.J., and BUDAPEST, HUNGARY, Dec. 16, 2010 /- Watson Pharmaceuticals, Inc. (NYSE: WPI ) ("Watson") and Gedeon Richter Plc ("Richter") today announced that Watson's subsidiary, Watson Laboratories, Inc. has entered into an exclusive licensing agreement with PregLem, S.A.,...

SABCS 2010 Interview with Amelie G. Ramirez, Dr.P.H.

December 15, 2010 1:33 pm | by AACR | News | Comments

Dr. Ramirez discusses the importance of genetic testing for breast cancer among Latinas, statewide and national communications programs, challenges facing the Hispanic community in reference to cancer, and how to address some of these concerns.

CyberKnife Centers of Miami and Palm Beach Announce New Chief Operating Officer

December 15, 2010 10:36 am | by Bio-Medicine.Org | News | Comments

MIAMI, Dec. 15, 2010 /- James G. Schwade, M.D., Executive Director of the CyberKnife Centers of Miami and Palm Beach, ( www.morsecyberknife.com ) is pleased to announce the appointment of Gail Suarez as the Chief Operating Officer. (Photo:...

SABCS Interview with Peter M. Ravdin, M.D., Ph.D.

December 15, 2010 10:36 am | by AACR | News | Comments

Dr. Ravdin talks about his work with SABCS, notable abstracts being presented, and his vision for the future of the SABCS.

Control Risks Forecasts New Reality for Business in 2011 Brought by Emerging Markets, Legislation

December 15, 2010 7:34 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, Dec. 15, 2010 /PRNewswire-USNewswire/ -- Control Risks , one of the world's leading business risk consultancies, today launches RiskMap 2011 – its annual review and forecast of business risk for the year ahead, including regional outlooks, and a rating of political and...

RoundTable Healthcare Partners Announces Sale of Clinical Innovations, LLC to The Pritzker Group

December 15, 2010 7:34 am | by Bio-Medicine.Org | News | Comments

LAKE FOREST, Ill., Dec. 15, 2010 /- RoundTable Healthcare Partners ("RoundTable"), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has entered into a definitive agreement to sell one of its portfolio companies, Clinical...

Pharmaceutical Institute Hires Nathan Pienkowski, Ph.D., to Head Instructional Design

December 15, 2010 7:34 am | by Bio-Medicine.Org | News | Comments

RALEIGH, N.C., Dec. 15, 2010 /- Pharmaceutical Institute, a leading provider of specialized training solutions for the pharmaceutical and biotech industry and a subsidiary of Campbell Alliance, has appointed Nathan Pienkowski, Ph.D., as Instructional Design Director.  In this role,...

Johnson & Johnson Announces Executive Appointments: Alex Gorsky, Vice Chairman, Executive Committee Sheri McCoy, Vice Chairman, Executive Committee

December 15, 2010 7:34 am | by Bio-Medicine.Org | News | Comments

NEW BRUNSWICK, N.J., Dec. 15, 2010 /- Johnson & Johnson (NYSE: JNJ ) today announced that Alex Gorsky, currently Worldwide Chairman, Medical Devices & Diagnostics (MD&D) and Sheri McCoy, currently Worldwide Chairman, Pharmaceuticals, have been appointed Vice Chairmen of the...

NASDAQ Gives Dynatronics a Second Six-Month Extension for Minimum Bid Price Compliance

December 15, 2010 7:33 am | by Bio-Medicine.Org | News | Comments

SALT LAKE CITY, Dec. 15, 2010 /- Dynatronics Corporation (Nasdaq: DYNT ) today announced that NASDAQ has given the company until June 13, 2011, to comply with its $1 per share minimum bid rule. "Given the challenges of the general economy, we welcome the grant by NASDAQ of an additional...

DSM Expands Industrial Biocatalysis Platform With c-LEcta Agreement

December 14, 2010 10:34 pm | by Bio-Medicine.Org | News | Comments

PARSIPPANY, N.J. and LEIPZIG, Germany, Dec. 15 2010 /- DSM Pharmaceutical Products, the custom manufacturing organization of Royal DSM NV, today announces a license agreement with c-LEcta GmbH for proprietary screening technology. The agreement grants DSM rights to c-LEcta's proprietary...

UBM Canon Launches Medical Manufacturing Events in India and Brazil

December 14, 2010 9:35 am | by Bio-Medicine.Org | News | Comments

LOS ANGELES, Dec. 14, 2010 /- UBM Canon today announced medical manufacturing event plans for two fast-growth BRIC markets, India and Brazil, utilizing respectively its long established MEDTEC and Medical Design & Manufacturing (MD&M) brands. In October 19-20, 2011, the MEDTEC...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading